Related Experiment Videos
Bilel Benamor1,2, Hanene Sayadi1,2, Ines Bayar1,2
1Department of Endocrinology and Internal Medicine, Fattouma Bourguiba Hospital, Monastir. Tunisia.
La Tunisie Medicale
|January 15, 2025
Summary
Poor therapeutic adherence affects two-thirds of type 2 diabetes patients. Factors like younger age and less frequent follow-ups are linked to non-adherence, highlighting the need for patient education.
Area of Science:
- Endocrinology
- Public Health
- Clinical Pharmacy
Context:
- Type 2 diabetes (T2D) poses a significant global health challenge.
- Effective management and complication prevention rely on patient therapeutic adherence.
- Understanding adherence barriers is crucial for improving T2D patient outcomes.
Purpose:
- To determine the prevalence of poor therapeutic adherence in type 2 diabetes outpatients.
- To identify demographic and clinical factors associated with poor adherence to antihyperglycemic agents.
Summary:
- A cross-sectional study assessed adherence in 172 T2D outpatients using the MMAS-8 scale.
- The prevalence of poor adherence was 66.1%.
- Key factors linked to poor adherence included younger age (<65), lower education, infrequent consultations, lack of self-monitoring, and unawareness of glycemic targets.
Impact:
- Findings underscore a high rate of non-adherence among T2D patients.
- Identified factors provide targets for interventions to improve medication adherence.
- Emphasizes the critical role of patient education in enhancing therapeutic adherence and T2D management.